BIZENGRI vs GLEOSTINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. BIZENGRI and GLEOSTINE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BIZENGRI	GLEOSTINE
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ZENOCUTUZUMAB-ZBCO	LOMUSTINE
Manufacturer	Merus N.V.	Azurity
Dosage forms	Injectable	Capsule
Drug class	—	Alkylating Drug
Boxed warning	Boxed warning	Boxed warning
Half-life	—	about 16 to 48 hours — but note this is the half-life of lomustine's metabolites, not the parent drug
Treats	Lung Neoplasms, Small Cell Lung Carcinoma	Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease

bizengri gleostine

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

ZENOCUTUZUMAB-ZBCO

LOMUSTINE

Manufacturer

Merus N.V.

Azurity

Dosage forms

Injectable

Capsule

Drug class

—

Alkylating Drug

Boxed warning

Half-life

—

about 16 to 48 hours — but note this is the half-life of lomustine's metabolites, not the parent drug

Treats

Lung Neoplasms, Small Cell Lung Carcinoma

Brain Neoplasms, Colonic Neoplasms, Hodgkin Disease

Frequently asked questions

What is the difference between Bizengri and Gleostine?

Bizengri contains Zenocutuzumab-Zbco, while Gleostine contains Lomustine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.